Kailera Therapeutics, Inc. (KLRA) EBITDA
- 2026-06-30: Basis Reported; EBITDA -$121.27M*; Operating income -$121.37M; Depreciation and amortization $101.00K*.
- 2026-03-31: Basis Reported; EBITDA -$84.56M; Operating income (m); Depreciation and amortization (m).
- 2025-06-30: Basis Reported; EBITDA -$30.59M*; Operating income -$30.65M; Depreciation and amortization $62.00K*.
- 2025-03-31: Basis Reported; EBITDA -$20.4M; Operating income (m); Depreciation and amortization (m).
Complete source-backed ebitda history.
- Available history
- 2025-03-31 to 2026-03-31
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | -$121.27M* | -$121.37M | $101.00K* | (m) | (m) | (m) | -$77.53M* | (m) | $101.06M | (m) | (m) |
|---|
| 2026-03-31 | Reported | -$84.56M | (m) | (m) | (m) | (m) | (m) | -$68.31M | (m) | $70.87M | (m) | (m) |
|---|
| 2025-06-30 | Reported | -$30.59M* | -$30.65M | $62.00K* | (m) | (m) | (m) | -$26.23M* | (m) | $19.52M | (m) | (m) |
|---|
| 2025-03-31 | Reported | -$20.4M | (m) | (m) | (m) | (m) | (m) | -$18.20M | (m) | $10.13M | (m) | (m) |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|